연속 혈당 측정기 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Continuous Glucose Monitoring Meter Market size is expected to reach USD 57.81 Billion in 2034 from USD 15.63 Billion (2025) growing at a CAGR of 15.64% during 2026-2034.

The global continuous glucose monitoring meter market has experienced rapid growth due to increasing cases of diabetes worldwide. Continuous glucose monitoring systems measure glucose levels in real time throughout the day, providing patients and healthcare providers with valuable insights into blood sugar patterns. These devices help improve diabetes management by allowing patients to make timely adjustments to diet, medication, and lifestyle.

Market growth is driven by the rising global prevalence of diabetes and the increasing demand for advanced monitoring technologies. Continuous glucose monitoring meters provide more accurate and continuous data compared to traditional blood glucose testing methods. The development of wearable sensors and mobile application connectivity has also improved patient convenience and monitoring efficiency.

The future of the continuous glucose monitoring meter market appears highly promising as digital health technologies continue to evolve. Integration with smart insulin delivery systems and mobile health platforms may enable more personalized diabetes management. Increasing healthcare awareness and expanding access to diabetes care in developing regions will also support market growth. As technology improves patient monitoring capabilities, continuous glucose monitoring systems will play a vital role in diabetes care.

MARKET SEGMENTATION

By Component

• Sensors
• Transmitters
• Receivers

By Age Group

• Adults
• Children

By End User

• Home Care Settings
• Hospitals and Clinics

COMPANIES PROFILED

• DexCom Inc, Abbott Laboratories, F HoffmannLa Roche Ltd, Medironic plc, Nemaura Medical Inc, LifeScan Inc, Senseonics Holdings Inc US, A Menarini Diagnostics Srl, Medtrum Technologies Inc, B Braun SE
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL CONTINUOUS GLUCOSE MONITORING METER MARKET: BY COMPONENT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Component
• 4.2. Sensors Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Transmitters Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Receivers Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CONTINUOUS GLUCOSE MONITORING METER MARKET: BY AGE GROUP 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Age Group
• 5.2. Adults Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Children Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CONTINUOUS GLUCOSE MONITORING METER MARKET: BY END USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End User
• 6.2. Home Care Settings Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Hospitals and Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL CONTINUOUS GLUCOSE MONITORING METER MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Component
  • 7.2.2 By Age Group
  • 7.2.3 By End User
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Component
  • 7.3.2 By Age Group
  • 7.3.3 By End User
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Component
  • 7.4.2 By Age Group
  • 7.4.3 By End User
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Component
  • 7.5.2 By Age Group
  • 7.5.3 By End User
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Component
  • 7.6.2 By Age Group
  • 7.6.3 By End User
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL CONTINUOUS GLUCOSE MONITORING METER INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 DexCom Inc
  • 9.2.2 Abbott Laboratories
  • 9.2.3 F. Hoffmann-La Roche Ltd
  • 9.2.4 Medironic. Plc
  • 9.2.5 Nemaura Medical Inc
  • 9.2.6 LifeScan Inc
  • 9.2.7 Senseonics Holdings Inc. (US)
  • 9.2.8 A Menarini Diagnostics Srl
  • 9.2.9 Medtrum. Technologies Inc
  • 9.2.10 B. Braun SE